## Abstract ## Objectives Behavioural and psychological symptoms of dementia (BPSD) are common in Alzheimer's disease (AD), and are associated with significant distress for patient and carer. Certain behavioural and psychological symptoms have been associated with each other, leading to the sugges
Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease
β Scribed by Alessia Lanari; Francesco Amenta; Giorgio Silvestrelli; Daniele Tomassoni; Lucilla Parnetti
- Book ID
- 113775901
- Publisher
- Elsevier Science
- Year
- 2006
- Tongue
- English
- Weight
- 159 KB
- Volume
- 127
- Category
- Article
- ISSN
- 0047-6374
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Objectives: To evaluate the frequency and type of psychological and behavioural symptoms in alzheimer's disease (ad) patients in poland, in various stages of the disease. ## Method: One hundred and sixty-nine patients with a diagnosis of probable ad in global deterioration (gds) stages 3, 4, 5
## Abstract ## Objectives The origins of behavioural and psychological symptoms of dementia are still poorly understood. By focusing on piecemeal behaviours as opposed to more robust syndrome change valid biological correlates may be overlooked. Our understanding of BPSD via the identification of
## Abstract ## Background Nonβcognitive symptoms are a frequent feature of Alzheimer's disease (AD). Much of the literature that has accumulated pertains to crossβsectional prevalence of these symptoms. There has been relatively little attention paid to the longitudinal course of Behavioural and P
The objective of this study was to examine whether patients with Alzheimer's disease (AD) with subnormal vitamin B12 levels show more frequent behavioural and psychological symptoms of dementia (BPSD) than AD patients with normal vitamin B12 levels. The design was a prospective case-control study. T
## Abstract ## Objective Alzheimer's disease (AD) patients commonly suffer from behavioural and psychological symptoms of dementia (BPSD). A genetic component to the development of BPSD in AD has been supported. Polymorphisms within dopamine receptors __DRD1, DRD2, DRD3__ and __DRD4__ have previou